Treatment outcomes in patients with laryngotracheal lesions and compromised airway during and prior to the coronovirus disease 2019 pandemic: a tertiary institution's experience.


Journal

The Journal of laryngology and otology
ISSN: 1748-5460
Titre abrégé: J Laryngol Otol
Pays: England
ID NLM: 8706896

Informations de publication

Date de publication:
Oct 2021
Historique:
pubmed: 14 8 2021
medline: 1 10 2021
entrez: 13 8 2021
Statut: ppublish

Résumé

This study aimed to compare treatment outcomes in patients with laryngeal and tracheal stenosis treated during and prior to the coronavirus disease 2019 pandemic period. Patients treated for laryngotracheal lesions with impending airway compromise during the active pandemic period were matched with those treated for similar lesions in the preceding years in a monocentric tertiary hospital setting. During the pandemic period of 55 days, 31 patients underwent 47 procedures. Seven patients (2 children, 5 adults) had open airway surgery, and one had an operation-specific complication. Twenty-four patients (10 children, 14 adults) underwent 40 endoscopic interventions without any complications. Operation specific results during and prior to the pandemic were comparable. The management strategy in patients with laryngotracheal lesions and impending airway compromise should not be altered during periods of risk from coronavirus disease 2019. Avoiding a tracheostomy by performing primary corrective surgery or proceeding with a definitive decannulation would be beneficial in these patients to reduce the risk of contagion.

Identifiants

pubmed: 34384506
doi: 10.1017/S0022215121002140
pii: S0022215121002140
pmc: PMC8387687
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

897-903

Auteurs

E Gombert (E)

Department of Otolaryngology, Lausanne University Hospital CHUV, Switzerland.

A Ishii (A)

Department of Otolaryngology, Lausanne University Hospital CHUV, Switzerland.

P Guilcher (P)

Department of Otolaryngology, Lausanne University Hospital CHUV, Switzerland.

F Gorostidi (F)

Department of Otolaryngology, Lausanne University Hospital CHUV, Switzerland.

G Cantarella (G)

Department of Clinical Sciences and Community Health, University of Milan, Italy.
Department of Otolaryngology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

L Pignataro (L)

Department of Clinical Sciences and Community Health, University of Milan, Italy.
Department of Otolaryngology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

K Sandu (K)

Department of Otolaryngology, Lausanne University Hospital CHUV, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH